文献速递介入妇产影像外周血管CTDSA

晚期妇科癌症患者严重子宫出血:血管内治疗在急性和慢性情况下的获益

Severe metrorrhagia in patients with advanced gynecologic cancer: endovascular treatment benefits in acute and chronic setting.
PubMed 文献 · Radiol Med · 2020-07-13

单中心回顾性分析30例晚期妇科癌症(III或IV期)伴急性或慢性子宫出血、不适合手术的患者,于2016年1月至2018年12月接受血管内栓塞治疗。初始CT血管造影显示2例(6.6%)对比剂外渗,DSA显示28例(93.4%)肿瘤染色,2例(6.6%)假性动脉瘤。作者认为血管内治疗可能是有效的治疗替代选择,尤其对临床状况差、不适合手术的老年患者,建议行双侧超选择性栓塞并使用不可吸收栓塞剂,但存在大血管浸润导致假性动脉瘤或瘘需栓塞的情况除外。

要点

  • DSA肿瘤染色检出率93.4%(28/30),高于初始CT血管造影对比剂外渗的6.6%(2/30)。
  • 2例(6.6%)DSA发现假性动脉瘤。
  • 作者建议双侧超选择性栓塞并使用不可吸收栓塞剂,大血管浸润致假性动脉瘤或瘘者除外。

核心结论

  • 作者认为对肿瘤患者子宫出血行血管内治疗可能是有效的治疗替代选择,尤其适用于临床状况差、不适合手术的老年患者。
  • 作者建议行双侧超选择性栓塞并使用不可吸收栓塞剂,但大血管浸润导致假性动脉瘤或瘘需栓塞的情况除外。

研究设计与样本

  • 单中心回顾性分析,纳入30例妇科癌症患者,于2016年1月至2018年12月因急性或慢性子宫出血接受血管内栓塞治疗。
  • 所有患者均为晚期肿瘤分期(III或IV期),肿瘤有局部区域扩散或侵犯盆腔结构,体能状态差,不适合手术。
  • 以初始CT血管造影和DSA为影像评估手段。

关键影像表现/征象

  • 初始CT血管造影显示2例(6.6%)对比剂外渗。
  • DSA检查显示28例(93.4%)肿瘤染色。
  • 2例(6.6%)DSA报告假性动脉瘤。

临床应用与阅片要点

  • 作者建议行双侧超选择性栓塞并使用不可吸收栓塞剂,但大血管浸润导致假性动脉瘤或瘘需栓塞的情况除外。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Interventional radiology plays an established role in the management of many conditions of the female reproductive tract. Since in benign gynecological and obstetric pathologies, as myomas and postpartum hemorrhages, uterine arteries embolization has been already evaluated, this manuscript aims to report on a single-center experience concerning the endovascular management of metrorrhagia caused by gynecological malignancies.

MATERIALS AND METHODS: Single-center retrospective analysis of thirty patients affected by gynecologic cancer treated with endovascular embolization between January 2016 and December 2018 for acute or chronic metrorrhagia.

RESULTS: All patients were in advanced oncological stage (III or IV) with loco-regional spread of the tumor or invasion of pelvic structures, with a poor performance status. They were not suitable for surgery. On initial CT angiography, contrast media extravasation was confirmed in two patients (6.6%), while on DSA examination, tumor stain was displayed in 28 patients (93.4%). In two patients (6.6%) a pseudoaneurysm was reported.

CONCLUSIONS: Endovascular treatment of metrorrhagia in oncologic patients could be a valid therapeutic alternative, especially when in elderly patients with poor clinical conditions not suitable for surgery. A bilateral and superselective embolization using non-resorbable embolic agents should be performed, except for those cases in which there is infiltration of major vessels causing pseudoaneurysms or fistulas that require embolization.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Coppola M, Giurazza F, Corvino F, et al. Severe metrorrhagia in patients with advanced gynecologic cancer: endovascular treatment benefits in acute and chronic setting. Radiol Med. 2020. PMID: 32661778. doi:10.1007/s11547-020-01251-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。